skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Head and neck cancer in HIV patients and their parents: a Danish cohort study

Original Research

(1454) Views  (297) Full article downloads

Authors: Engsig FN, Gerstoft J, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Obel N

Published Date July 2011 Volume 2011:3(1) Pages 217 - 227
DOI: http://dx.doi.org/10.2147/CLEP.S19875

Frederik N Engsig1, Jan Gerstoft1, Gitte Kronborg2, Carsten S Larsen3, Gitte Pedersen4, Court Pedersen5, Niels Obel1
1Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark; 2Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark; 3Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; 4Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark; 5Department of Infectious Diseases, Odense University Hospital, Odense, Denmark

Background: The mechanism for the increased risk of head and neck cancer (HNC) observed in HIV patients is controversial. We hypothesized that family-related risk factors increase the risk of HNC why we estimated the risk of this type of cancer in both HIV patients and their parents.
Methods: We estimated the cumulative incidence and incidence rate ratios (IRRs) of HNC in 1) a population of all Danish HIV patients identified from the Danish HIV Cohort Study (n = 5053) and a cohort of population controls matched on age and gender (n = 50,530) (study period; 1995–2009) and 2) the parents of HIV patients and population controls (study period 1978–2009). To assess the possible impact of human papilloma virus (HPV)–associated cancers, the sites of squamous cell HNCs were categorized as HPV related, potentially HPV related, and potentially HPV unrelated.
Results: Seventeen (0.3%) HIV patients vs 80 (0.2%) population controls were diagnosed with HNC cancer in the observation period. HIV patients had an increased risk of HNC (IRR 3.05 [95% CI 1.81–5.15]). The IRR was considerably increased in HIV patients older than 50 years (adjusted IRR; 4.58 [95% CI 2.24–9.35]), diagnosed after 1995 (adjusted IRR 6.31 [95% CI 2.82–14.08]), previous or current smoker (adjusted IRR 4.51 [95% CI 2.47–8.23]), with baseline CD4 count 350 cells/µL (adjusted IRR; 3.89 [95% CI 1.95–7.78]), and men heterosexually infected with HIV (adjusted IRR 5.54 [95% CI 1.96–15.66]). Fifteen (83%) of the HIV patients diagnosed with HNC were current or former smokers. The IRR of squamous cell HNC in HIV patients was high at HPV-relate sites, potentially HPV-related sites, and potentially HPV-unrelated sites. Both fathers and mothers of HIV patients had an increased risk of HNC (adjusted IRR for fathers 1.78 [95% CI 1.28–2.48], adjusted IRR for mothers 2.07 [95% CI 1.05–4.09]).
Conclusion: HIV appears to be a marker of behavioral or family-related risk factors that affect the incidence of HNC in HIV patients.

Keywords: HIV, head and neck cancer incidence, matched cohort, population controls, parents




 

Other articles by Dr F N Engsig



Readers of this article also read:

Pupillography of automated swinging flashlight test in amblyopia
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Diabetes, glycemic control and risk of medical glaucoma treatment: A population-based case-control study
Hepatitis C virus infection and risk of cancer: a population-based cohort study
Tuberculosis mortality in HIV-infected individuals: a cross-national systematic assessment
Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision
Erratum
Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates
Epidemiology of invasive fungal infections in kidney transplant patients